Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Neutropenia

Neutron source Neutron sources Neutrons, thermal Neutropenia... [Pg.668]

The oxa2ohdinedione trimethadione [127-48-0] C H NO (50), at one time the dmg of choice for the treatment of absence sei2ures, has been replaced by ethosuximide (41) and valproate (49). (50) has a distinct profile from that of phenytoin but causes photophobia and night blindness in approximately 30% of the patients taking it and has the CNS and sedative properties seen for other anticonvulsants together with moderate neutropenia, hepatitis, and skin rashes (13). Trimethadione does not appear to produce its effects via modulation of GABA-mediated responses. [Pg.537]

GM-CSF, G-CSF, M-CSF, multi-CSF cytotoxic injury bone marrow transplantation myelodysplastic syndromes AIDS neutropenia rodent and human... [Pg.41]

Similar results have been reported in sublethaHy and lethaHy irradiated dogs, where G-CSF reduced the severity and duration of neutropenia and the duration of thrombocytopenia (161). G-CSF increases the survival of lethaHy irradiated animals by inducing eadier recovery of neutrophils and platelets. GM-CSF also decreases the severity and duration of neutropenia in dogs exposed to 2.4 Gy (2400 rad) TBI, but does not influence monocyte or lymphocyte recovery (162), indicating its expected selective action. [Pg.494]

Clinically, GM-CSF or G-CSF have been used to accelerate recovery after chemotherapy and total body or extended field irradiation, situations that cause neutropenia and decreased platelets, and possibly lead to fatal septic infection or diffuse hemorrhage, respectively. G-CSF and GM-CSF reproducibly decrease the period of granulocytopenia, the number of infectious episodes, and the length of hospitalization in such patients (152), although it is not clear that dose escalation of the cytotoxic agent and increased cure rate can be rehably achieved. One aspect of the effects of G-CSF and GM-CSF is that these agents can activate mature cells to function more efficiently. This may, however, also lead to the production of cytokines, such as TNF- a, that have some toxic side effects. In general, both cytokines are reasonably well tolerated. The side effect profile of G-CSF is more favorable than that of GM-CSF. Medullary bone pain is the only common toxicity. [Pg.494]

Vinorelbine) taxol [33069-62 ] C47H51NO14 853.92 (52) nonsmaH cell lung cancer investigational dmg alopecia neutropenia ... [Pg.441]

Capecitabine is used for the treatment of colorectal and breast cancers. It is contraindicated in patients with known hypersensitivity to capecitabine or any of its components or to 5-fluorouracil and in patients with known dihydropyrimidine dehydrogenase (DPD) deficiency. The use of capecitabine is restricted in patients with severe renal impairment. The drag can induce diarrhea, sometimes severe. Other side effects include anemia, hand-foot syndrome, hyperbilirubinemia, nausea, stomatitis, pyrexia, edema, constipation, dyspnea, neutropenia, back pain, and headache. Cardiotoxicity has been observed with capecitabine. A clinically important drag interaction between capecitabine and warfarin has been demonstrated. Care should be exercised when the drag is co-administered with CYP2X9 substrates. [Pg.150]

Azacitidine is used for treating patients with some myelodysplastic syndrome subtypes and chronic mye-lomonocytic leukemia. The most commonly occurring adverse reactions include nausea, anemia, thrombocytopenia, vomiting, pyrexia, leucopenia, diarrhea, fatigue, neutropenia, and ecchymosis. [Pg.152]

Decitabine is specifically indicated for the treatment of multiple types of myelodysplastic syndromes and chronic myelomonocytic leukemia. As anticipated, use of decitabine is associated with bone marrow suppression including neutropenia and thrombocytopenia which are the most frequently observed serious adverse effects. [Pg.152]

Recombinant human DL-1 receptor antagonist (Anakinra, Kineret ) blocks the biological activity of interleukin-1 by competitively inhibiting IL-1 binding to the interleukin-1 type I receptor (IL-1RI), which is expressed in a wide variety of tissues and organs. Thereby it reduces the pro-inflammatory activities of IL-1 including cartilage destiuction and bone resorption. Side effects include an increased risk of infections and neutropenia. [Pg.412]

Neutropenia is a drop in the number of circulating leukocytes, especially neutrophils. It can be induced by a variety of drugs. Treatment with cytotoxic antineo-plastic drags usually results in severe neutropenia, which can be treated with colony-stimulating factors (G-CSF, GM-CSF). [Pg.846]

Hematologic—neutropenia, eosinophilia, leukopenia, pancytopenia, thrombocytopenia, agranulocytosis, and aplastic anemia... [Pg.162]

The most common serious adverse reactions to amantadine are orthostatic hypotension, depression, congestive heart failure, psychosis, urinary retention, convulsions, leukopenia, and neutropenia Less serious reactions include hallucinations, confusion, anxiety, anorexia, nausea, and constipation. Adverse reactions with selegiline include nausea, hallucinations, confusion, depression, loss of balance, and dizziness. [Pg.267]

Anemia, proteinuria, nausea, vomiting, fever, rash, leukopenia, neutropenia, thrombocytopenia, diarrhea, constipation, alopecia Bone marrow depression, hyperuricemia, hepatotoxicity, skin rash... [Pg.586]

Nausea, skin rash, pruritus, stomatitis, vomiting, anemia, leukopenia, neutropenia, arthralgia, alopeda, asthenia, fever, infections Diarrhea, nausea, vomiting, flushing, myalgia, arthralgia, fever, peripheral neuropathy, opportunistic infections Leukopenia, nausea, vomiting, paresthesias, malaise, weakness, mental depression, headache, hypertension, alopecia, diarrhea, constipation... [Pg.586]

The drug was subsequently reintroduced for treatment-resistant or treatment-intolerant patients in the UK and USA in 1990. The drug is completely free of extrapyramidal side effects but has to be monitored for the development of neutropenia and agranulocytosis. Other problems include sialorrhoea, sedation, reduction in seizure... [Pg.91]

Ognibene, F.P., Martin, S.E. and Parker, M.M. (1986). Adult respiratory distress syndrome in patients with severe neutropenia. N. Engl. J. Med. 315, 547-551. [Pg.230]

Ticlopidine is slightly more beneficial in stroke prevention than aspirin in both men and women.31,32 The usual recommended dosage is 250 mg orally twice daily. Ticlopidine is costly, and side effects include bone marrow suppression, rash, diarrhea, and an increased cholesterol level. Neutropenia is seen in approximately 2% of patients. Thrombotic thrombocytopenic... [Pg.170]


See other pages where Neutropenia is mentioned: [Pg.238]    [Pg.385]    [Pg.494]    [Pg.494]    [Pg.433]    [Pg.133]    [Pg.170]    [Pg.183]    [Pg.183]    [Pg.200]    [Pg.200]    [Pg.411]    [Pg.416]    [Pg.581]    [Pg.846]    [Pg.846]    [Pg.1497]    [Pg.121]    [Pg.122]    [Pg.585]    [Pg.585]    [Pg.654]    [Pg.64]    [Pg.123]    [Pg.55]    [Pg.215]    [Pg.610]    [Pg.120]    [Pg.25]    [Pg.171]   
See also in sourсe #XX -- [ Pg.610 ]

See also in sourсe #XX -- [ Pg.271 ]

See also in sourсe #XX -- [ Pg.49 , Pg.86 , Pg.93 , Pg.118 , Pg.263 , Pg.264 , Pg.273 , Pg.278 , Pg.281 , Pg.282 ]

See also in sourсe #XX -- [ Pg.239 , Pg.259 ]

See also in sourсe #XX -- [ Pg.246 ]

See also in sourсe #XX -- [ Pg.262 , Pg.263 ]

See also in sourсe #XX -- [ Pg.521 , Pg.729 ]

See also in sourсe #XX -- [ Pg.14 ]

See also in sourсe #XX -- [ Pg.132 , Pg.138 ]

See also in sourсe #XX -- [ Pg.83 , Pg.87 ]

See also in sourсe #XX -- [ Pg.343 , Pg.373 , Pg.381 , Pg.389 ]

See also in sourсe #XX -- [ Pg.51 , Pg.105 ]

See also in sourсe #XX -- [ Pg.175 , Pg.176 ]

See also in sourсe #XX -- [ Pg.59 ]

See also in sourсe #XX -- [ Pg.1798 , Pg.1892 , Pg.1910 ]

See also in sourсe #XX -- [ Pg.28 ]

See also in sourсe #XX -- [ Pg.453 , Pg.462 ]

See also in sourсe #XX -- [ Pg.17 , Pg.25 ]

See also in sourсe #XX -- [ Pg.699 ]

See also in sourсe #XX -- [ Pg.738 ]

See also in sourсe #XX -- [ Pg.197 ]

See also in sourсe #XX -- [ Pg.90 ]

See also in sourсe #XX -- [ Pg.316 ]

See also in sourсe #XX -- [ Pg.511 ]

See also in sourсe #XX -- [ Pg.358 , Pg.359 , Pg.366 ]

See also in sourсe #XX -- [ Pg.172 ]

See also in sourсe #XX -- [ Pg.185 ]

See also in sourсe #XX -- [ Pg.188 ]




SEARCH



Abacavir neutropenia

Agranulocytosis neutropenia

Cancer chemotherapy neutropenia caused

Cancer febrile neutropenia

Cancer neutropenia

Chemotherapy neutropenia

Cyclic neutropenia

Diazoxide neutropenia

Docetaxel neutropenia

Febrile neutropenia anthracycline

Febrile neutropenia cyclophosphamide

Interleukin neutropenia

Lithium neutropenia

Neutropenia INDEX

Neutropenia anthracycline

Neutropenia case study

Neutropenia causes

Neutropenia chemotherapy-induced

Neutropenia chemotherapy-related

Neutropenia cidofovir

Neutropenia clinical findings

Neutropenia clinical presentation

Neutropenia clozapine

Neutropenia colony-stimulating factors

Neutropenia congenital

Neutropenia definition

Neutropenia diagnosis

Neutropenia drug-induced

Neutropenia febrile

Neutropenia in cancer patients

Neutropenia mirtazapine

Neutropenia olanzapine

Neutropenia prophylactic antibiotics

Neutropenia prophylaxis

Neutropenia trastuzumab

Neutropenia treatment

Neutropenia valganciclovir

Neutropenia with antipsychotics

Neutropenia, CSFs

Neutropenia-inducing drugs

Paclitaxel neutropenia

Ribavirin neutropenia

Ticlopidine neutropenia

© 2024 chempedia.info